This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jung, S. K. Articles by Dong, Z. Search for Related Content PubMed PubMed Citation Articles by Jung, S. K. Articles by Dong, Z. Related Collections Preclinical Intervention Preclinical Intervention: In Vivo (Animals): Drugs, Nutritional Interventions, Mechanisms

Myricetin Suppresses UVB-Induced Skin Cancer by Targeting Fyn

¹ Department of Agricultural Biotechnology, Seoul National University; ² Department of Bioscience and Biotechnology and ³ Department of Chemistry, Konkuk University, Seoul, Republic of Korea; ⁴ The Hormel Institute, University of Minnesota, Austin, Minnesota; and ⁵ University of Arizona Cancer Center, Tucson, Arizona

Requests for reprints: Hyong Joo Lee, Department of Agricultural Biotechnology, Seoul National University, Seoul 151-742, Republic of Korea. Phone: 82-2-880-4860; Fax: 82-2-873-5095; E-mail: leehyjo{at}snu.ac.kr or Zigang Dong, Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, MN 55912. Phone: 507-437-9600; Fax: 507-437-9606; E-mail: zgdong{at}hi.umn.edu.

Key Words: Fyn • myricetin • skin cancer

Skin cancer is currently the most common type of human cancer in Americans. Myricetin, a naturally occurring phytochemical, has potent anticancer-promoting activity and contributes to the chemopreventive potential of several foods, including red wine. Here, we show that myricetin suppresses UVB-induced cyclooxygenase-2 (COX-2) expression in mouse skin epidermal JB6 P+ cells. The activation of activator protein-1 and nuclear factor-B induced by UVB was dose-dependently inhibited by myricetin treatment. Western blot and kinase assay data revealed that myricetin inhibited Fyn kinase activity and subsequently attenuated UVB-induced phosphorylation of mitogen-activated protein kinases. Pull-down assays revealed that myricetin competitively bound with ATP to suppress Fyn kinase activity. Importantly, myricetin exerted similar inhibitory effects compared with 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine, a well-known pharmacologic inhibitor of Fyn. In vivo mouse skin data also revealed that myricetin inhibited Fyn kinase activity directly and subsequently attenuated UVB-induced COX-2 expression. Mouse skin tumorigenesis data clearly showed that pretreatment with myricetin significantly suppressed UVB-induced skin tumor incidence in a dose-dependent manner. Docking data suggest that myricetin is easily docked to the ATP-binding site of Fyn, which is located between the N and C lobes of the kinase domain. Overall, these results indicated that myricetin exerts potent chemopreventive activity mainly by targeting Fyn in skin carcinogenesis. [Cancer Res 2008;68(14):6021–9]

This article has been cited by other articles:

				F J. Duncan, J. R. Martin, B. C. Wulff, G. D. Stoner, K. L. Tober, T. M. Oberyszyn, D. F. Kusewitt, and A. M. Van Buskirk Topical Treatment with Black Raspberry Extract Reduces Cutaneous UVB-Induced Carcinogenesis and Inflammation Cancer Prevention Research, July 1, 2009; 2(7): 665 - 672. [Abstract] [Full Text] [PDF]